NCT04819906View on ClinicalTrials.gov

Effect of Estetrol Monohydrate (E4) on QTc Interval

PHASE1CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

March 9, 2021

Primary Completion Date

July 14, 2021

Study Completion Date

July 14, 2021

Conditions
Prolonged QTc Interval
Interventions
DRUG

Estetrol 20 mg

One estetrol monohydrate (E4) 20 mg tablet plus four matching placebo tablets orally once

DRUG

Estetrol 100 mg

Five estetrol monohydrate (E4) 20 mg tablets orally once

DRUG

Placebo

Five placebo tablets orally once

DRUG

Moxifloxacin 400 mg

One moxifloxacin 400 mg tablet orally once (open-label)

Trial Locations (1)

33143

QPS Miami, Miami

Sponsors

Lead Sponsor

Estetra
All Listed Sponsors
lead

Estetra

INDUSTRY

NCT04819906 - Effect of Estetrol Monohydrate (E4) on QTc Interval | Biotech Hunter | Biotech Hunter